Antimicrobial Resistance and Infection Control 2014,3 :31
A review of available evidence (2016).
28-29 June 2016; Geneva, Switzerland
The END TB strategy.
PLOS ONE | DOI:10.1371/journal.pone.0133869 July 28, 2015, p.1-16
Information note
Accessed November 2017.
Guidelines for Handling Temperature Sensitive Vaccines and Pharmaceuticals
Public Health Fact Sheet
Involving the Community in Responding to TB/HIV: Outcomes of Community-Led Monitoring and Advocacy
Accessed November 2017
Collection of country-level good practices
Annex 1: Measuring progress towards targets
Annex 2: Modelling the impact of the 90-(90)-90 strategy
Annex 3: Investment packages by country setting
Annex 4: Country strategies
Annex 5: Strategic frameworks for research and development for new tools
Annex 6 : Estimating the cost of the 90-(90)-...90 strategy
Accessed November 2017
more
Data received as of July 3, 2017 | WHO and UNICEF estimates of national immunization coverage - next revision available July 15, 2018
This guidance is intended for use in developing standalone TB strategic plans, or TB interventions as part of multidisease or health sector plans. It describes key considerations and steps for strategic planning for TB in line with the World Health Organization’s End TB strategy, and the proposed ...structure of the NSP. The target audience of this publication are all stakeholders involved in national strategic planning for TB (e.g., ministry of health, other government ministries, private sector, civil society, affected communities, academic and research institutions, and technical and funding partners).
The current document is an update to the 2015 Toolkit to develop a national strategic plan for TB prevention, care and control.
more
WHO/CDS/TB/99.272
Distr.: General, Original: French
NHSP 2017- 2022 (Final draft)